The Role of NMP22 and CSTB Levels in Predicting Postoperative Recurrence of Bladder Cancer by Changkun Huang, Xiaolin Ai, Liping Hu, Da Ren

“…To investigate the value of preoperative urinary nuclear matrix protein 22 (NMP22) and Cystatin B (CSTB) expressions in evaluating the postoperative recurrence of bladder cancer. Methods. The clinical case data of 102 patients with bladder cancer who underwent surgical treatment from January 2017 to January 2022 were collected, and the patients were divided into a recurrence group (n=54) and nonrecurrence group (n=48) according to whether the patients recurred after surgery, and the preoperative NMP22 and CSTB expression levels between the two groups were compared. …”
Get full text

Kidney Function After Prostate and Urinary Bladder Cancer Surgery in Iraqi People by Ali Alasady

Get full text

Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer by Yuki Arita, Thomas C. Kwee, Oguz Akin, Keisuke Shigeta, Ramesh Paudyal, Christian Roest, Ryo Ueda, Alfonso Lema-Dopico, Sunny Nalavenkata, Lisa Ruby, Noam Nissan, Hiromi Edo, Soichiro Yoshida, Amita Shukla-Dave, Lawrence H. Schwartz

“…Abstract Bladder cancer is the 10th most common and 13th most deadly cancer worldwide, with urothelial carcinomas being the most common type. …”
Get full text

Conservative Management of Muscle Invasive Bladder Cancer in Kidney-Pancreas Transplant Patient by Logan D. Glosser, Brandon S. Zakeri, Conner V. Lombardi, Obi O. Ekwenna

“…Solid organ transplant increases the risk for muscle-invasive bladder cancer (MIBC). Although a common tumor, urothelial cell carcinoma (UCC) of the bladder in patients with kidney-pancreas transplants is scarcely reported. …”
Get full text

Health-Related Quality of Life after Cystectomy and Urinary Diversion for Bladder Cancer by Cheryl Shih, Michael P. Porter

“…With multiple options for urinary diversion after radical cystectomy for bladder cancer that have comparable cancer control and complication rates, health-related quality of life (HRQOL) has become an important consideration. …”
Get full text

Nanoparticle Therapies: Targeted Treatment for Bladder Cancer With Reduced Side Effects [Letter] by Sun J

Subjects: Get full text

Disseminated M. bovis Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer by Harpreet S. Gill, Suhas P. Dasari, Sarbagya Pandit, Thomas E. Ritter, Sushma B. Raju, Alexander R. Chartier, Pinky Jha

“…The use of BCG in immunotherapy for bladder cancer has been in practice for over 40 years. …”
Get full text

Redefining bladder cancer treatment: innovations in overcoming drug resistance and immune evasion by Peng Huang, Jie Wang, Zongze Yu, Jiaan Lu, Zhou Sun, Zhigui Chen

Subjects: “…bladder cancer…”
Get full text

Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer by Farhan Haq, Samudra Sabari, Jaromir Háček, Antonín Brisuda, Ines Ambite, Michele Cavalera, Parisa Esmaeili, Murphy Lam Yim Wan, Shahram Ahmadi, Marek Babjuk, Catharina Svanborg

Subjects: “…non‐muscle invasive bladder cancer…”
Get full text

Metastatic Bladder Cancer Presenting with Persistent Hematuria in Young Man with Cystic Fibrosis by Premal Patel, Harvey R. Rabin, Michael M. Vickers, Michael D. Parkins

“…We report a case of metastatic bladder cancer developing in a young man with cystic fibrosis (CF) that was initially diagnosed as ureterolithiasis and managed as renal colic. …”
Get full text

Transcriptome-wide association study identifies genes associated with bladder cancer risk by Siting Li, Jiang Gui, Margaret R. Karagas, Michael N. Passarelli

Subjects: “…Bladder Cancer…”
Get full text

Diagnosis of Bladder Cancer with Urinary Cytology, Immunocytology and DNA-Image-Cytometry1 by Bernhard Planz, Christian Synek, Thomas Deix, Alfred Böcking, Michael Marberger

“…DNA‐image‐cytometry and antibodies directed against the Lewis X‐ and the 486p 3/12 antigen were applied to improve diagnostic accuracy of urinary cytology for the detection of bladder cancer. Cytology, immunocytology and DNA‐image‐cytometry were performed in spontaneously voided urine samples and barbotage bladder washings from 71 patients. …”
Get full text

Molecular profiling of bladder cancer xenografts defines relevant molecular subtypes and provides a resource for biomarker discovery. by Sharada Mokkapati, Ganiraju Manyam, Alexis R. Steinmetz, Côme Tholomier, Alberto Martini, Woonyoung Choi, Bogdon Czerniak, Byron H Lee, Colin P Dinney, David J McConkey

Subjects: “…Bladder cancer…”
Get full text

Molecular Detection of Bladder Cancer by Fluorescence Microsatellite Analysis and an Automated Genetic Analyzing System by Sarel Halachmi, Michal Cohen, Raymond Szargel, Nadin Cohen

“…To investigate the ability of an automated fluorescent analyzing system to detect microsatellite alterations, in patients with bladder cancer. We investigated 11 with pathology proven bladder Transitional Cell Carcinoma (TCC) for microsatellite alterations in blood, urine, and tumor biopsies. …”
Get full text

Blood lead levels and bladder cancer among US participants: NHANES 1999–2018 by Mei Huang, Hongxiao Li, Jiahui Chen, Liuqiang Li, Yifei Zhan, Yuxuan Du, Jun Bian, Meiling Chen, Dehui Lai

Subjects: Get full text

Management of the Uncommon Bladder Cancers: A Single-Center Experience over 10 Years by Youssef Kadouri, Salim Lachkar, Hamza Dergamoun, Hachem El Sayegh, Lounis Benslimane, Yassine Nouini

“…Under the name of uncommon bladder cancers are gathered rare histological entities which represent less than 5% of bladder tumors. …”
Get full text

The prognostic effect of immunohistochemical staining rates in patients with non–muscle-invasive bladder cancer by Aykut Demirci, Melike Ordu

Subjects: “…bladder cancer…”
Get full text

The Role of the Key Differentially Mutated Gene FGFR3 in the Immune Microenvironment of Bladder Cancer by Jun Jiang, Yan Zhan, Jun Li

“…The tumor microenvironment (TME) has been a major focus of research in recent years as a crucial factor in the development and progression of bladder cancer. Unfortunately, the precise composition of TME, particularly the immunological and stromal components, remains unknown. …”
Get full text

Prognostic evaluation of non-muscle invasive bladder cancer with P-CRP and its nomogram by Junyun Wu, Zhixuan Deng, Xu Lei, Zhiyao Xu, Chenxi Tan, Yunqiao Tang, Xi Sheng, Ning Yang

Subjects: “…non-muscle invasive bladder cancer…”
Get full text

SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway by Yuwen Gong, Dongyang Gao, Yibo Shi, Guangrui Fan, Xiaoquan Yu, Enguang Yang, Hui Cheng, Junqiang Tian, Hui Ding, Shanhui Liu, Shengjun Fu, Yan Tao, Yuan Shui, Liang Cheng, Lanlan Li, Zhiping Wang

“…Abstract The development of cisplatin resistance often results in a grim prognosis in advanced or recurrent bladder cancer. However, effective treatment strategies for cisplatin resistance have not been well established. …”
Get full text